Feasibility and Evaluation of a Self-care App to Enhance Purposeful Living
- Conditions
- Ovarian Cancer
- Interventions
- Behavioral: Use of Purposeful app
- Registration Number
- NCT04458168
- Lead Sponsor
- University of Michigan Rogel Cancer Center
- Brief Summary
In this pilot study, ovarian cancer survivors will be enrolled and followed for six months to evaluate usage of an eHealth app called "Purposeful".
- Detailed Description
This study will determine the feasibility and acceptability of Purposeful, the eHealth app. First, feasibility of enrolling ovarian cancer survivors to use Purposeful will be assessed. Secondly, the acceptability of the app among ovarian cancer survivors will be assessed, based on frequency of use and validated acceptability measures. Participants will be asked to complete other validated questionnaires so investigators may explore whether further research on the Purposeful app among ovarian cancer survivors is warranted. This will include correlations between use of the Purposeful app and the life purpose questionnaire score. Lastly, correlation between life purpose and quality of life in ovarian cancer survivors will be explored.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 120
- Diagnosis of ovarian cancer or treatment for ovarian cancer through the University of Michigan Gynecologic Oncology service
- Completed primary treatment (either surgery alone or surgery + chemotherapy)
- Ability to understand and the willingness to sign a written informed consent
- Ability to speak and read English
- There are no additional exclusion criteria for participation in this study.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Recurrence of ovarian cancer Use of Purposeful app 25 women who have experienced a recurrence of their ovarian cancer after primary treatment Recently completed treatment Use of Purposeful app 25 women who have just completed treatment No recurrence of ovarian cancer for at least one year Use of Purposeful app 25 women who have not experienced a recurrence of their ovarian cancer at least one year after their initial diagnosis
- Primary Outcome Measures
Name Time Method Feasibility assessed by enrollment rate At time of enrollment The number of patients who enroll in the study, of the total number of patients approached for enrollment.
Feasibility assessed by percentage of days of app use 6 months Percentage of days during a 6-month period on which each participant used the Purposeful app. Using the app during the day is defined as doing at least one of the following: setting an intention; completing a reflection; completing an action. Usage data will be provided by the Purposeful app.
Feasibility assessed by trajectory of usage on a percent of days used on both a weekly and monthly time scale. 6 months The average percentage of days of app use per week and per month during a 6-month period. Using the app during the day is defined as doing at least one of the following: setting an intention; completing a reflection; completing an action. Usage data will be provided by the Purposeful app.
Acceptability assessed by percentage of patients who find the Purposeful app to be acceptable 6 months A score of 3 or more on the acceptability summary score (assessed using a protocol-specific questionnaire) will indicate that the patient finds the Purposeful app to be acceptable.
- Secondary Outcome Measures
Name Time Method Change in quality of life assessed using Functional Assessment of Cancer Therapy-Ovarian (FACT-O) Trial Outcome Index (TOI) (FACT-O TOI) 6 months Assessed at baseline, 1, 3 and 6 months. FACT-O TOI is a 26-item questionnaire that sums the physical well-being, functional well-being, and additional health concerns with a 7-day recall period. All items will be rated on a 5 items (point) Likert Scale, from 0 (not at all) to 4 (very much so). To score the FACT-O TOI, all 26 items will be summed to create a single score with a range from 0 to 104. Items will be reverse scored when appropriate to provide a scale in which a higher score represent a higher quality of life.
Change in life purpose from baseline 6 months Assessed at baseline, 1, 3 and 6 months using the Modified Ryff and Keyes Scales of Psychological Well-being evaluation, a 7-item questionnaire that uses a Likert scale ranging from 1 to 6, with higher scores indicating greater purpose in life.
Change in quality of life using Comprehensive Measure of Meaning (Well-being questionnaire Part 10) 6 months Assessed at baseline, 1, 3 and 6 months. The Comprehensive Measure of Meaning (Well-being questionnaire Part 10) is a 21-item questionnaire that uses a Likert scale ranging from 1 to 7, with higher scores indicating greater well-being.
Change in quality of life assessed using Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) 6 months Assessed at baseline, 1, 3 and 6 months. The FACIT-fatigue scale is a 13-item patient-reported measure of fatigue with a 7-day recall period. All items will be rated on a 5 items (point) Likert Scale, from 0 (not at all) to 4 (very much so). To score the FACIT-fatigue, all 13 items will be summed to create a single fatigue score with a range from 0 to 52. Items will be reverse scored when appropriate to provide a scale in which a higher score represent less fatigue.
Trial Locations
- Locations (1)
University of Michigan Rogel Cancer Center
🇺🇸Ann Arbor, Michigan, United States